Cargando…
Combination of multiple omics techniques for a personalized therapy or treatment selection
Despite targeted therapies and immunotherapies have revolutionized the treatment of cancer patients, only a limited number of patients have long-term responses. Moreover, due to differences within cancer patients in the tumor mutational burden, composition of the tumor microenvironment as well as of...
Autores principales: | Massa, Chiara, Seliger, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565668/ https://www.ncbi.nlm.nih.gov/pubmed/37828984 http://dx.doi.org/10.3389/fimmu.2023.1258013 |
Ejemplares similares
-
The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
por: Seliger, Barbara, et al.
Publicado: (2013) -
Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways
por: Seliger, Barbara, et al.
Publicado: (2022) -
Immune Therapy Resistance and Immune Escape of Tumors
por: Seliger, Barbara, et al.
Publicado: (2021) -
The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment—Review
por: Seliger, Barbara
Publicado: (2019) -
Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity
por: Seliger, Barbara
Publicado: (2019)